Magazine Article | April 1, 2022

3 Essentials For A Fit-For-Purpose Compliance Strategy In Decentralized Pharma

Source: Life Science Leader

By Penelope Przekop, MSQA , RQA P-GCP, and Valerie Przekop

Outsourcing and technology have morphed our industry into a new decentralized model. Now, each sponsor must carefully develop an ongoing compliance strategy considering its unique business model and its influence on the drug development journey. Strategies are needed to design quality management systems (QMSs) that can expand and pivot in tandem with corporate and clinical development.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: